Key facts
- This page summarizes Suneel Gupta's Form 4 filing for Protagonist Therapeutics, Inc (PTGX).
- 12 reported transactions and 5 derivative rows are listed below.
- Accepted by SEC: 27 Nov 2024, 19:09.
Suneel Gupta - 25 Nov 2024 Form 4 Insider Report for Protagonist Therapeutics, Inc (PTGX)
- Reporting relationship
- Chief Development Officer
- Issuer ticker
- PTGX
- Reported as of
- 25 Nov 2024
- Net transaction value
- -$3,908,853
- SEC form
- 4
- Accepted by SEC
- 27 Nov 2024, 19:09:12 UTC
- Prior SEC filing
- 28 Feb 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Matthew Gosling, Attorney-in-Fact for Suneel Gupta
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Suneel Gupta filed Form 4 for Protagonist Therapeutics, Inc (PTGX) on 27 Nov 2024.
Change
- Previous filing in this sequence was filed on 28 Feb 2024.
- Current net transaction value: -$3,908,853.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
PTGX
transaction
Common Stock
Options Exercise
- Transaction value
- $332,100
- Shares
- +45,000
- Change %
- +24%
- Price
- $7.38
- Shares after
- 229,611
- Date
- 25 Nov 2024
- Ownership
- Direct
- Footnotes
- F1
PTGX
transaction
Common Stock
Options Exercise
- Transaction value
- $360,900
- Shares
- +45,000
- Change %
- +20%
- Price
- $8.02
- Shares after
- 274,611
- Date
- 25 Nov 2024
- Ownership
- Direct
PTGX
transaction
Common Stock
Options Exercise
- Transaction value
- $663,000
- Shares
- +85,000
- Change %
- +31%
- Price
- $7.80
- Shares after
- 359,611
- Date
- 25 Nov 2024
- Ownership
- Direct
PTGX
transaction
Common Stock
Sale
- Transaction value
- $4,762,239
- Shares
- -103,437
- Change %
- -29%
- Price
- $46.04
- Shares after
- 256,174
- Date
- 25 Nov 2024
- Ownership
- Direct
- Footnotes
- F2, F3
PTGX
transaction
Common Stock
Options Exercise
- Transaction value
- $365,100
- Shares
- +30,000
- Change %
- +12%
- Price
- $12.17
- Shares after
- 286,174
- Date
- 26 Nov 2024
- Ownership
- Direct
PTGX
transaction
Common Stock
Sale
- Transaction value
- $873,190
- Shares
- -19,191
- Change %
- -6.7%
- Price
- $45.50
- Shares after
- 266,983
- Date
- 26 Nov 2024
- Ownership
- Direct
- Footnotes
- F2, F4
PTGX
transaction
Common Stock
Options Exercise
- Transaction value
- $5,476
- Shares
- +450
- Change %
- +0.17%
- Price
- $12.17
- Shares after
- 267,433
- Date
- 26 Nov 2024
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
PTGX
transaction
Derivative
Stock Option (right to buy)
Options Exercise
- Transaction value
- $0
- Shares
- -45,000
- Change %
- -100%
- Price
- $0.000000
- Shares after
- 0
- Date
- 25 Nov 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 45,000
- Exercise price
- $7.38
- Footnotes
- F5
PTGX
transaction
Derivative
Stock Option (right to buy)
Options Exercise
- Transaction value
- $0
- Shares
- -45,000
- Change %
- -100%
- Price
- $0.000000
- Shares after
- 0
- Date
- 25 Nov 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 45,000
- Exercise price
- $8.02
- Footnotes
- F5
PTGX
transaction
Derivative
Stock Option (right to buy)
Options Exercise
- Transaction value
- $0
- Shares
- -85,000
- Change %
- -100%
- Price
- $0.000000
- Shares after
- 0
- Date
- 25 Nov 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 85,000
- Exercise price
- $7.80
- Footnotes
- F5
PTGX
transaction
Derivative
Stock Option (right to buy)
Options Exercise
- Transaction value
- $0
- Shares
- -30,000
- Change %
- -24%
- Price
- $0.000000
- Shares after
- 93,750
- Date
- 26 Nov 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 30,000
- Exercise price
- $12.17
- Footnotes
- F6
PTGX
transaction
Derivative
Stock Option (right to buy)
Options Exercise
- Transaction value
- $0
- Shares
- -450
- Change %
- -0.48%
- Price
- $0.000000
- Shares after
- 93,300
- Date
- 26 Nov 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 450
- Exercise price
- $12.17
- Footnotes
- F6
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 6 footnotes
Footnote F1
Includes an aggregate of 1,326 shares acquired by the Reporting Person under the Issuer's 2016 Employee Stock Purchase Plan on March 9, 2024.
Footnote F2
Sale to cover the exercise price of the options.
Footnote F3
The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $45.63 to $46.50. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
Footnote F4
The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $45.23 to $45.81. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
Footnote F5
These stock options are fully vested.
Footnote F6
The stock option vests in 48 equal monthly installments following the date of grant.